Acelity Revenue and Competitors

Location

$2M

Total Funding

Estimated Revenue & Valuation

  • Acelity's estimated annual revenue is currently $1.1B per year.(i)
  • Acelity's estimated revenue per employee is $401,600
  • Acelity's total funding is $2M.
  • Acelity's current valuation is $6.7B. (May 2019)

Employee Data

  • Acelity has 2808 Employees.(i)
  • Acelity grew their employee count by -3% last year.

Acelity's People

NameTitleEmail/Phone
1
Regional VP, General Manager ANZReveal Email/Phone
2
VP FinanceReveal Email/Phone
3
VP, Head Global Tax (Acelity)/Senior Tax Counsel—Planning (3M)Reveal Email/Phone
4
VP, Franchise Leader, Post AcuteReveal Email/Phone
5
VP - Corporate ControllerReveal Email/Phone
6
Director, Global Travel & Meetings ManagementReveal Email/Phone
7
Director, Corporate AccountsReveal Email/Phone
8
Director, AWT Operations IntegrationReveal Email/Phone
9
Director Business TransformationReveal Email/Phone
10
Domestic Tax DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.6M7421%N/AN/A
#2
$37.7M150-7%N/AN/A
#3
$1.4M11-31%$5.1MN/A
#4
$49.7M19814%N/AN/A
#5
$1.3M100%$6.3MN/A
#6
$60.7M242N/AN/AN/A
#7
$28.1M1128%N/AN/A
#8
$5.5M22-19%N/AN/A
#9
$3M12-20%N/AN/A
#10
$10.3M41N/AN/AN/A
Add Company

What Is Acelity?

Acelity is a global wound care and regenerative medicine company created by uniting the strengths of three companies, Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited. We are committed to advancing the science of healing and restoring people’s lives. Available in more than 75 countries, the innovative and complementary Acelity product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Headquartered in San Antonio, Texas, Acelity employs more than 5,500 people around the world. We believe in enabling better futures for everyone.

keywords:N/A

$2M

Total Funding

2808

Number of Employees

$1.1B

Revenue (est)

-3%

Employee Growth %

$6.7B

Valuation

N/A

Accelerator

Acelity News

2022-04-20 - Radiodermatitis Market Size And Forecast | 3M Healthcare ...

3M Healthcare, BMG Pharma, ConvaTec Inc, Acelity LP, Alliqua Biomedical, Integra Life Sciences, Intermed Pharmaceuticals, Molnlycke Health Care...

2022-04-20 - Traditional Wound Care Market Size And Forecast | Acelity LP ...

Acelity L.P. Inc., Smith & Nephew plc, Baxter International Inc., Coloplast A/S, Medtronic plc, M lnlycke Health Care AB, Ethicon Inc.,...

2022-04-19 - Wound Debridement Market to Exhibit a Remarkable CAGR ...

Acelity L.P. Inc, Smith & Nephew, B. Braun Melsungen AG, ConvaTec Group, Coloplast , Paul Hartmann, Mölnlycke Health Care,...

2019-05-02 - 3M to Acquire Acelity

3M (NYSE: MMM) is to acquire global medical technology company Acelity, Inc., and its KCI subsidiaries worldwide, for a total enterprise value of approximately $6.7 billion. The seller was a consortium comprised of funds advised by Apax Partners (the Apax Funds), together with controlled affili ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$927.4M30116%N/A
#2
$452.8M31717%N/A
#3
$1240.2M32127%$14.6M
#4
$666.7M3284N/AN/A
#5
$1340M37467%$10M